Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
通常取引
$18.19
+$0.50 · +2.83%
日中の時刻はETです。市場データは遅延する場合があります。
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
日中レンジ
現在 $18.19
52週レンジ
現在 $18.19
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
66
強気
リスク
59
やや高いリスク
モメンタム
50
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
日中レンジ
現在 $18.19
52週レンジ
現在 $18.19
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 22.48億 USD | 21.08億 USD | 17.07億 USD | 15.63億 USD | 14.26億 USD |
| 売上原価 | 9.03億 USD | 9.27億 USD | 7.16億 USD | 6.94億 USD | 6.49億 USD |
| 粗利益 | 13.45億 USD | 11.81億 USD | 9.91億 USD | 8.69億 USD | 7.78億 USD |
| 研究開発 | 1.2億 USD | 9129.8万 USD | 7533.1万 USD | 6082.7万 USD | 4909.4万 USD |
| 販売・一般管理 | 10.7億 USD | 9.39億 USD | 8.3億 USD | 7.73億 USD | 6.66億 USD |
| 営業費用 | 13.64億 USD | 19.56億 USD | 10.56億 USD | 9.41億 USD | 8.4億 USD |
| 受取利息 | — | — | — | 20万 USD | — |
| 支払利息 | 3482.3万 USD | 5710万 USD | 1974.9万 USD | 2495.2万 USD | 2911.2万 USD |
| 減価償却費と償却費 | 2.94億 USD | 2.85億 USD | 2.17億 USD | 2.2億 USD | 2.63億 USD |
| 営業利益 | −1886.9万 USD | −7.76億 USD | −6570.9万 USD | −7117.8万 USD | −6279.9万 USD |
| 純利益 | −11.84億 USD | −8.25億 USD | −3326.1万 USD | −1329.2万 USD | 7165.7万 USD |
会社概要が更新されました 2026年10月12日.
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$36.33
上昇余地(99.73%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2022年4月5日 | 1:3 | — | — |
発効済み 2022年4月5日
1:3
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。